Verisk Analytics CFO's Stock Sale Part of Pre-Planned Trading Strategy

Rhea-AI Filing Summary

Elizabeth Mann, Chief Financial Officer of Verisk Analytics (VRSK), reported selling 300 shares of common stock at a price of $308.90 per share on June 17, 2025. The transaction was executed under a pre-established 10b5-1 trading plan that Mann initiated on December 13, 2024.

Following the transaction, Mann continues to directly own 16,065 shares of Verisk Analytics common stock. The sale represents a relatively small portion of her total holdings, suggesting this is likely part of a routine portfolio management strategy rather than a significant shift in position.

Key transaction details:

• Transaction was executed pursuant to Rule 10b5-1 trading plan
• Total transaction value: approximately $92,670
• Direct ownership maintained through remaining shares
• No derivative securities were involved in this transaction

Insider Trade Summary

Net Seller: 300 shares ($92,670)

Net Sell 1 txn

Insider Mann Elizabeth

Role Chief Financial Officer

Sold 300 shs ($93K)

Type	Security	Shares	Price	Value
Sale	Common Stock	300	$308.90	$93K

Holdings After Transaction: Common Stock — 16,065 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mann Elizabeth

(Last) (First) (Middle)

C/O VERISK ANALYTICS, INC.

545 WASHINGTON BOULEVARD

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		S		300	D	$308.9(1)	16,065	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 13, 2024.

	/s/ Kathy Card Beckles, Attorney-in-fact	06/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of VRSK stock did CFO Elizabeth Mann sell on June 17, 2025?

According to the Form 4 filing, CFO Elizabeth Mann sold 300 shares of Verisk Analytics (VRSK) common stock at a price of $308.90 per share on June 17, 2025.

How many VRSK shares does Elizabeth Mann own after the June 2025 transaction?

Following the reported transaction, Elizabeth Mann directly owns 16,065 shares of Verisk Analytics (VRSK) common stock.

Was VRSK CFO Elizabeth Mann's stock sale part of a pre-planned trading plan?

Yes, the shares were sold pursuant to a Rule 10b5-1 trading plan that Ms. Mann established on December 13, 2024, as disclosed in the footnotes of the Form 4 filing.

What is Elizabeth Mann's role at VRSK as disclosed in the Form 4?

Elizabeth Mann serves as the Chief Financial Officer of Verisk Analytics (VRSK), as indicated in Section 5 of the Form 4 filing where her relationship to the issuer is disclosed.

What was the total value of VRSK shares sold by Elizabeth Mann in this transaction?

The total value of the transaction was $92,670, calculated from the sale of 300 shares at a price of $308.90 per share.